Sheeba Kuriakose
Family · Richmond, VANPI 1891414280
Payments from drug & device makers
Across 235 payments — averaging $22.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$833
- Novo Nordisk$679
- Pfizer$462
- Sumitomo Pharma America, Inc.$432
- Lilly USA, LLC$422
- GSK$333
- plus $2K from 24 others
What the payments were for
- Food & beverage$5,306100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $833 |
| Novo Nordisk | 27 | $679 |
| Pfizer | 23 | $462 |
| Sumitomo Pharma America, Inc. | 22 | $432 |
| Lilly USA, LLC | 23 | $422 |
| GSK | 9 | $333 |
| Insulet Corporation | 3 | $329 |
| Bayer | 15 | $238 |
| Otsuka America Pharmaceutical, Inc. | 5 | $221 |
| Novartis | 5 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $142 |
| Eisai Inc. | 3 | $135 |
| AstraZeneca | 8 | $127 |
| Boehringer Ingelheim | 6 | $118 |
| Cequr Corporation | 3 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $81 |
| Exact Sciences | 4 | $69 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $64 |
| Sunovion Pharmaceuticals Inc. | 4 | $62 |
| Astellas Pharma US Inc | 3 | $47 |
| Sanofi-aventis U.S. LLC | 2 | $43 |
| Xeris Pharmaceuticals, Inc. | 2 | $38 |
| Mylan Specialty L.p. | 2 | $37 |
| Ardelyx, Inc. | 2 | $32 |
| Merck | 2 | $28 |
| Dexcom, Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $17 |
| Lexicon Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,306 in reported general payments places this provider in the 90th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $93,048 |
| JardianceEmpagliflozin | 60 | $45,745 |
| JanuviaSitagliptin Phosphate | 24 | $31,885 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $27,151 |
| EliquisApixaban | 28 | $22,435 |
| FarxigaDapagliflozin Propanediol | 24 | $21,732 |
| TrulicityDulaglutide | 15 | $18,021 |
| VraylarCariprazine Hcl | 11 | $15,627 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 14 | $12,825 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 16 | $4,446 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 32 | $3,975 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 72 | $2,180 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 98 | $1,191 |
| Atorvastatin Calcium | 158 | $1,119 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 60 | $815 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $679 | $93,04871 claims |
| Boehringer IngelheimJardiance | $118 | $45,74560 claims |
| MerckJanuvia | $28 | $31,88524 claims |
| GSKTrelegy Ellipta | $333 | $27,15127 claims |
| PfizerEliquis | $462 | $22,43528 claims |
| AstraZenecaFarxiga | $127 | $21,73224 claims |
| Lilly USA, LLCTrulicity | $422 | $18,02115 claims |
| AbbVieVraylar | $833 | $15,62711 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $21 | $43844 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,332 family providers in Virginia.
Other family in Richmond
- Hochong Smith GillesRichmond$131K
- Kasiah BanksRichmond$29K
- Johanna ChristensenRichmond$24K
- Megan ZoltyRichmond$11K
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Sean OlaughlinMidlothian$110K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.